MILFORD, Mass.--(BUSINESS WIRE)--Waters Corporation (NYSE:WAT) announced today the introduction of the ACQUITY™ UPLC PLUS Series, three new ACQUITY UltraPerformance LC™ (UPLC™) Systems that build off ...

Let us help you with your inquiries, brochures and pricing requirements Request A Quote Download PDF Copy Request A Quote Download PDF Copy Request A Quote Download ...

Waters® Corporation today celebrated the ten-year anniversary of the ACQUITY® UltraPerformance LC® (UPLC®) System, a technology that created a new industry standard for chromatographic performance.

Waters Corporation has recently published its ACQUITY UPLC Columns brochure for separations scientists. This 12-page, color brochure explains the design strategy behind Waters' newest column family.

The ACQUITY UPLC I-Class PLUS System offers industry-leading separations performance, opening up new possibilities for maximizing the resolution and sensitivity of your methods, improving the ...

“In 2004, we changed the game. High Performance Liquid Chromatography (HPLC) wasn't keeping pace with business demands to analyze more samples, faster and with better results. The introduction of ...

MILFORD, Mass.--(BUSINESS WIRE)-- Waters Corporation (NYSE:WAT) today introduced ACQUITY™ PREMIER Columns, a new family of premium sub-2-micron columns featuring MaxPeak™ High Performance Surface (HPS ...

MILFORD, Mass., Oct. 20 Waters Corporation (NYSE: WAT) announced today that the U.S. Food and Drug Administration's Center for Food Safety and Applied Nutrition (CFSAN), College Park, MD recently ...

Waters Corporation announced that the Waters ACQUITY UPLC I-Class IVD/Xevo TQ-S micro IVD System is now manufactured as a U. FDA Class I medical device and is CE Marked to the European Directive 98/79 ...

Ernie Hillier from Waters shows us their Acquity Patrol Laboratory Analyzer. It is a walk-up system that uses UPLC, liquid chromatography technology and is suited to such things as process development ...

The approval of ACQUITY UPLC is important for Waters as well as China. Notably, this marks the second medical device approval for Waters, the first being a neonatal screening solution which included ...